PSI CRO AG

Deciding whether your clinical trial needs a data safety monitoring board can be difficult due to the lack of set guidelines to help provide direction and the complexity of setting them up and managing them once in place. Swipe through to look at some of our top things to consider when deciding to implement a DSMB, and read the full white paper at https://lnkd.in/eMPGaHWe

For drug developers in the burgeoning field of radiopharmaceuticals, the University of Missouri Research Reactor (MURR) is the essential first stop. PSI was proud to join the MURR team to discuss how Mizzou’s innovations are shaping the future of precision medicine. https://bit.ly/4cCcXZF

In our latest spotlight story, we dive into Bo's journey to discovering her passion for clinical research and her professional growth at PSI: https://lnkd.in/eGanfGxh #PSIProud #PSICareers

Connect with our team later this month in San Diego at the 3rd Targeted Radiopharmaceuticals Summit US! Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget and learn why more than 95% of PSI’s customers are repeat or referrals. https://bit.ly/3Wd17j4

Increasing diversity in clinical trials is a top priority for our industry, and the FDA has just released a draft guidance to assist sponsors in this critical goal. Learn what's included and how to start planning here. https://bit.ly/4cNrVw1

A Data Monitoring Committee (DMC), also known as a Data and Safety Monitoring Board (DSMB), is a powerful mechanism for managing risks to trial participant safety and well-being and data validity and integrity. Learn about the most common challenges sponsors face with DMC setup and administration based on PSI's 20+ years of experience managing these committees. https://bit.ly/3VF3A4o

We are proud to have received recognition from our sponsors for the seventh year in a row in the CRO Leadership Awards. This honor helps us continue our ongoing mission to be the best clinical research organization in the world as measured by our employees, clients, investigative sites, and vendors. Read the full press release here: https://bit.ly/4bi0MAC

Join us next week in Boston for Clinical Trials in Oncology East Coast! Catch our session on July 10 at 12:00 to learn how PSI can help you manage uncertainty during your upcoming oncology clinical trial. Schedule some time to meet with our team at booth #27 now: https://bit.ly/4bFmY83

For drug developers in the burgeoning field of radiopharmaceuticals, the University of Missouri Research Reactor (MURR) is the essential first stop. PSI was proud to join the MURR team to discuss how Mizzou’s innovations are shaping the future of precision medicine. https://bit.ly/4cCcXZF

How do you achieve success by leveraging strong site relationships around the globe? PSI worked with the sponsor of a Phase 2 trial in rare ovarian tumors with an exceedingly small patient population and wide global spread to complete enrollment more than two years ahead of schedule. Read the full case study at https://bit.ly/3y0YlEa